Real-World Experience with Injectable -Based Lenacapavir Regimens in Patients with HIV-1: A Descriptive Study

Conference Reports for NATAP

IDSA
ID Week 2026
October 21-24
Washington, DC


Real-World Experience with Injectable -Based Lenacapavir Regimens in Patients with HIV-1: A Descriptive Study

	IDSA 2026 October 21-23 Wash DC Madison Patrus, DO; Brianna Hohmann, DO; Smitha Gudipati, MD; Nicholas Yared MD; Indira Brar, MD Henry Ford Health, Detroit, Michigan